Baluba, Shainne .

HRN: 16-55-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
CEFUROXIME 1.5GM (VIAL)
12/03/2024
12/10/2024
INTRAVENOUS
570 Mg
Every 8 Hours
Acute Tonsillopharyngitis, PCAP-A
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: